Amanta Healthcare files SEBI Reg 29(2) disclosure for Bhavesh G Patel
The company submitted a Regulation 29(2) filing on 1 July 2026 indicating a substantial share acquisition by Bhavesh G Patel, though specific details were not disclosed.
What Amanta Healthcare announced
Amanta Healthcare Ltd (BSE: 544502) filed a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on 1 July 2026. The filing pertains to Bhavesh G Patel, indicating that he has made a substantial acquisition of the company's shares. The announcement itself contains no further quantitative information – such as the number of shares acquired, the acquisition price, or the percentage of total equity represented.
Details of the Regulation 29(2) filing
Regulation 29(2) requires any person who acquires shares that cross the 5% threshold of a listed company's equity to disclose the acquisition to the stock exchange within two working days. The purpose is to ensure transparency for investors and regulators. In this case, the filing confirms that Bhavesh G Patel has crossed that threshold, but the exact figures have not been provided in the public document.
"The Exchange has received the disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 for Bhavesh G Patel." – BSE filing, 1 July 2026.
The lack of detail is not uncommon in initial Reg 29(2) notices; a more detailed statement, often called a “Form 13D” equivalent, may follow once the acquirer finalises the transaction and the shareholding percentage is confirmed.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Amanta Healthcare Ltd |
| BSE Code | 544502 |
| Filing date | 1 July 2026 |
| Regulation invoked | SEBI Regulation 29(2) (SAST) |
| Acquirer | Bhavesh G Patel |
| Shareholding disclosed | Not specified |
| Source | BSE filing (PDF) |
Why this matters for investors
The filing signals a potential shift in the ownership structure of Amanta Healthcare. A substantial shareholder can influence corporate strategy, board composition, and future capital decisions. While the exact size of Patel’s stake is unknown, the fact that a Reg 29(2) notice was triggered suggests a holding of at least 5% of the company’s equity. Investors should watch for subsequent disclosures that will reveal the precise percentage and any related agreements, such as lock‑in periods or voting rights arrangements.
Conclusion
Amanta Healthcare has formally notified the market of a significant share acquisition by Bhavesh G Patel under SEBI’s SAST framework. The initial filing does not disclose the magnitude of the stake, leaving a gap that will likely be filled in later communications. Stakeholders should stay alert for follow‑up filings that will clarify the extent of the acquisition and its possible implications for corporate governance.
Frequently asked questions
Related stocks
Source filing: view original